Physician profile
Joshua Mcdaniel
NPI 1245999770
$3,184.72
in general payments reported to CMS, 2019-2025
16 companies · $680 in 2025
The $680 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $91.27 · 2023: $1,120 · 2024: $1,294 · 2025: $680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,998 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,998.46 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $897.58 | 2023-2025 | |
| Abbvie INC. | $823.80 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $315.66 | 2023-2025 | Dupixent, Libtayo |
| Ucb, INC. | $264.70 | 2024-2025 | Bimzelx |
| Verrica Pharmaceuticals INC. | $158.65 | 2023-2024 | Ycanth |
| E.R. Squibb & Sons, L.L.C. | $148.10 | 2022-2024 | Sotyktu |
| Janssen Biotech, INC. | $126.74 | 2023-2024 | Tremfya |
| Organogenesis INC. | $81.97 | 2024-2025 | Cygnus Dual |
| Incyte Corporation | $81.46 | 2022-2024 | Opzelura |
| Novartis Pharmaceuticals Corporation | $81.32 | 2024 | |
| Pfizer INC. | $68.06 | 2023-2024 | |
| Lilly USA, LLC | $57.14 | 2024-2025 | Taltz, Ebglyss, Olumiant |
| Amgen INC. | $25.89 | 2024 | Otezla |
| Almirall LLC | $20.92 | 2025 | Klisyri |
| Sun Pharmaceutical Industries INC. | $19.35 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biowound Solutions, INC. | $13.38 | 2025 | Bio-Connekt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Mcdaniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.